Details of CPPsite entry with Sequence KGRKKRRQRRRPPQ |
| Primary information | |
|---|---|
| PEPTIDE SEQUENCE | KGRKKRRQRRRPPQ |
| CPPsite ID | 2478, 2479, |
| PEPTIDE NAME | d-NTD, q-NTD |
| CHIRALITY | L, L |
| LINEAR/CYCLIC | Linear, Linear |
| SOURCE | Protein derived, Protein derived |
| CATEGORY | Cationic, Cationic |
| SUB CELLULAR LOCALIZATION | Lysosome, Lysosome |
| N-TERMINAL MODIFICATION | Acetylation, Acetylation |
| C-TERMINAL MODIFICATION | Amidation, Amidation |
| CHEMICAL MODIFICATION | Doxorubicin is attached by a cathepsin B degradable tetrapeptide linker (-Gly-Phe-Leu-Gly-)., Doxorubicin is attached by a cathepsin B degradable tetrapeptide linker (-Gly-Phe-Leu-Gly-). |
| UPTAKE EFFICIENCY | d-NTD is the most potent conjugate against HepG2 human liver cancer cells, q-NTD accumulated most effectively within cancer cells |
| PROPOSED UPTAKE MECHANISM | Endocytic pathway, Endocytic pathway |
| INVITRO/INVIVO | In vitro, In vitro |
| CELL LINE | HepG2, HepG2 |
| In VIVO MODEL | NA, NA |
| CARGO | Small molecule drug (Doxorubicin), Small molecule drug (Doxorubicin) |
| PMID | 24892976, 24892976 |
| PATENT | Unknown, Unknown |
| Tertiary Structure (Technique) | 2478 (PEPstrMOD), 2479 (PEPstrMOD), |